Adagene Inc. (ADAG)
NASDAQ: ADAG · IEX Real-Time Price · USD
2.520
-0.010 (-0.40%)
Jul 26, 2024, 1:39 PM EDT - Market closed
Adagene Market Cap
Adagene has a market cap or net worth of $111.56 million as of July 26, 2024. Its market cap has increased by 64.30% in one year.
Market Cap
111.56M
Enterprise Value
36.68M
1-Year Change
64.30%
Ranking
Category
Stock Price
$2.52
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $111.56M, a decrease of -86.13%. That is a compound annual growth rate of -43.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 111.60M | 31.91% |
| Dec 29, 2023 | 84.60M | 47.13% |
| Dec 30, 2022 | 57.50M | -83.10% |
| Dec 31, 2021 | 340.30M | -57.69% |
| Feb 9, 2021 | 804.22M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regulus Therapeutics | 115.22M |
| AEON Biopharma | 114.63M |
| KORU Medical Systems | 113.72M |
| Coya Therapeutics | 112.03M |
| Augmedix | 111.75M |
| TELA Bio | 110.95M |
| CytomX Therapeutics | 110.65M |
| InterCure | 109.83M |